Novel 3,6-disubstituted 7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines: Synthesis, characterization, and evaluation of analgesic / anti-inflammatory, antioxidant activities

Archiv der Pharmazie

Volumn 342, Issue 5, 2009, Pages 291-298

  Tozkoparan, Birsen ^a   Aytaç, Sevim Peri ^a   Aktay, Göknur ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

1,2,4 triazolo 3,4 b 1,3,4 thiadiazines; 4 amino 3 mercapto 1,2,4 triazole; Analgesic activity; Anti inflammatory activity; Antioxidant activity

Indexed keywords

1,2,4 TRIAZOLO[3,4 B][1,3,4]THIADIAZINE DERIVATIVE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; INDOMETACIN; THIADIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; GASTROINTESTINAL TOXICITY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH LESION;

ACETIC ACID; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CARRAGEENAN; DRUG EVALUATION, PRECLINICAL; EDEMA; FEMALE; LIPID PEROXIDATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED BALB C; SPECTROPHOTOMETRY, INFRARED; STOMACH ULCER; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZINES; TRIAZOLES;

EID: 66349108764     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800188     Document Type: Article

References (37)

1. A. Robert, Adv. Prostaglandin Thromboxane Res. 1976, 2, 507-520.
2. M. C. Allison, A. G. Howatson, C. J. Torrance, F. D. Lee, R. I. Russel, N. Engl. J. Med. 1992, 327, 749-754.
3. C. J. Smith, Y. Zhang, C. M. Koboldt, J. Muhammad, et al., Proc. Natl. Acad. Sci. U.S.A. 1998, 95(22), 13313-13318.
4. T. D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, et al., Proc. Natl. Acad. Sci. U.S.A. 1999, 96(13), 7563-7568.
5. C. Hawkey, L. Laine, T. Simon, A. Beaulieu, et al., Arthritis Rheum. 2000, 43(2), 370-377.
6. A. S. Kalgutkar, A. B. Marnett, B. C. Crews, R. P. Remmel, L. J. Marnett, J. Med. Chem. 2000, 43(15), 2860-2870.
7. M. Duflos, M. R. Nourrisson, J. Brelet, J. Courant, G. LeBaut, et al., Eur. J. Med. Chem. 2001, 36(6), 545-553.
8. A. S. Kalgutkar, S. W. Rowlinson, B. C. Crews, L. J. Marnett, Bioorg. Med. Chem. Lett. 2002, 12(4), 521-524.
9. A. S. Kalgutkar, B. C. Crews, S. Saleh, D. Prudhomme, L. J. Marnett, Bioorg. Med. Chem. 2005, 13(24), 6810-6822.
10. S. Khanna, M. Madan, A. Vangoori, R. Banerjee, et al., Bioorg. Med. Chem. 2006, 14(14), 4820-4833.
11. M. D. Mullican, M. W. Wilson, D. T. Connor, C. R. Kostlan, et al., J. Med. Chem. 1993, 36(8), 1090-1099.
12. L. Labanauskas, V. Kalcas, E. Udrenaite, P. Gaidelis, et al., Pharmazie 2001, 56(8), 617-619.
13. E. Palaska, G. Sahin, P. Kelicen, N. T. Durlu, G. Altinok, Il Farmaco 2002, 57(2), 101-107.
14. M. Amir, K. Shikha, Eur. J. Med. Chem. 2004, 39(6), 535-545.
15. L. Labanauskas, E. Udrenaite, P. Gaidelis, A. Brukstus, Il Farmaco 2004, 59(4), 255-259.
16. M. Amir, S. Kumar, Pharmazie 2005, 60(3), 175-180.
17. L. Navidpour, H. Shafaroodi, K. Abdi, M. Amini, et al., Bioorg. Med. Chem. 2006, 14(8), 2507-2517.
18. O. A. Al-Deeb, M. A. Al-Omar, N. R. El-Brollosy, E. E. Habib, et al., Arzneimittelforschung 2006, 56(1), 40-47.
19. U. Salgin-Göksen, N. Gökhan-Kelekçi, O. Göktas, Y. Köysal, et al., Bioorg. Med. Chem. 2007, 15(17), 5738-5751.
20. B. Tozkoparan, G. Ayhan-Kilcigil, R. Ertan, M. Ertan, et al., Arzneimittelforschung 1999, 49(12), 1006-1011.
21. B. Tozkoparan, G. Aktay, E. Yesilada, M. Ertan, Arzneimittelforschung 2001, 51(6), 470-477.
22. B. Tozkoparan, G. Aktay, E. Yesilada, Il Farmaco 2002, 57(2), 145-152.
23. B. Tozkoparan, N. Gökhan, E. Küpeli, E. Yesilada, M. Ertan, Arzneimittelforschung 2004, 54(1), 35-41.
24. B. Tozkoparan, E. Küpeli, E. Yesilada, S. Isik, et al., Arzneimittelforschung 2005, 55(9), 533-540.
25. B. Tozkoparan, E. Küpeli, E. Yesilada, M. Ertan, Bioorg. Med. Chem. 2007, 15(4), 1808-1814.
26. B. Tozkoparan, N. Gökhan, G. Aktay, E. Yesilada, M. Ertan, Eur. J. Med. Chem. 2000, 35(7-8), 743-750.
27. B. Berk, G. Aktay, E. Yesilada, M. Ertan, Pharmazie 2001, 56(8), 613-616.
28. E. Dogdas, B. Tozkoparan, F. B. Kaynak, L. Eriksson, et al., Arzneimittelforschung 2007, 57(4), 196-202.
29. S. P. Aytaç, M. S. Thesis, Hacettepe University, Health Sciences Institute, 2008.
30. F. P. Invidiata, G. Furnò, I. Lampronti, D. J. Simoni, J. Heterocycl. Chem., 1997, 34, 1255-1258.
31. G. Turan-Zitouni, Z. A. Kaplancikli, K. Erol, F. S. Kiliç, Il Farmaco, 1999, 54, 218-223.
32. A. R. Prasad, T. Ramalingam, A. B. Rao, P. V. Diwan, P. B. Sattur, Eur. J. Med. Chem. 1989, 24, 199-201.
33. P. Karegoudar, D. J. Prasad, M. Ashok, M. Mahalinga, et al., Eur. J. Med. Chem. 2008, 43(4), 808-815.
34. R. Koster, R. Anderson, E. J. De Beer, Fed. Proc. 1959, 18, 412.
35. Y. Kasahara, H. Hikino, S. Tsurufuji, M. Watanabe, K. Ohuchi, Planta Med., 1985, 51, 325-331.
36. H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 1979, 85, 351-358.
37. S. Jammal, J. C. Smith, Toxicol. Appl. Pharmacol. 1985, 80, 33-42.